TAPAZOLE Side Effects

7020547-1 | Anti-neutrophil Cytoplasmic Antibody Positive Vasculitis, Cross Sensitivity Reaction
on Sep 21, 2010 Female patient from UNITED STATES , 25 years of age, was diagnosed with basedow's disease, hyperthyroidism and was treated with Tapazole (View Usage). Patient experienced the following unwanted or unexpected effects: anti-neutrophil cytoplasmic antibody positive vasculitis, cross sensitivity reaction. Tapazole dosage: 10 Mg, Qd. During the same period patient was treated with PROPYLTHIOURACIL (50 Mg, Bid) (View Propylthiouracil Review and Propylthiouracil Label ).

6978203-1 | Central Nervous System Lesion, Dysarthria, Dysphagia, Dysuria, Fall, Hypoaesthesia, Loss Of Consciousness, Mental Impairment, Mydriasis
Patient was taking Tapazole (View Usage). Patient had the following side effects: central nervous system lesion, dysarthria, dysphagia, dysuria, fall (What is fall?), hypoaesthesia, loss of consciousness, mental impairment, mydriasis on Sep 09, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 132.0 lb, was diagnosed with migraine (What is migraine?), insomnia, multiple sclerosis (What is multiple sclerosis?) and. Tapazole dosage: 30 Mg, Qhs. During the same period patient was treated with TOPAMAX (View Topamax Review and Topamax Label ), VERAPAMIL HCL (120 Mg, Unk) (View Verapamil Hcl Review and Verapamil Hcl Label ), XANAX (Unk, Bid) (View Xanax Review and Xanax Label ), AMBIEN (Unk, Qhs) (View Ambien Review and Ambien Label ), NARCODORM (4 Df, Unk) (View Narcodorm Review and Narcodorm Label ). Patient was hospitalized and became disabled.

6970170-X | Cyanosis, Dysphagia, Dysphonia, Dyspnoea, Fatigue, Hypoventilation, Muscular Weakness, Myasthenia Gravis Crisis
Adverse event was reported on Aug 30, 2010 by a Female patient taking Tapazole (View Usage) (Dosage: ) was diagnosed with hyperthyroidism and. Location: CROATIA (local name: Hrvatska) , 34 years of age, After Tapazole was administered, patient had the following side effects: cyanosis, dysphagia, dysphonia, dyspnoea, fatigue, hypoventilation, muscular weakness, myasthenia gravis crisis. Patient was hospitalized.

6931506-9 | Central Nervous System Lesion, Dysarthria, Dysphagia, Fall, Hypoaesthesia, Loss Of Consciousness, Mental Impairment, Mydriasis, Neurological Symptom
on Aug 12, 2010 Female patient from UNITED STATES , weighting 132.0 lb, was diagnosed with migraine (What is migraine?), insomnia, multiple sclerosis (What is multiple sclerosis?) and was treated with Tapazole (View Usage). Patient experienced the following unwanted or unexpected effects: central nervous system lesion, dysarthria, dysphagia, fall (What is fall?), hypoaesthesia, loss of consciousness, mental impairment, mydriasis, neurological symptom. Tapazole dosage: 30 Mg, Qhs. During the same period patient was treated with TOPAMAX (View Topamax Review and Topamax Label ), VERAPAMIL (120 Mg, Unk) (View Verapamil Review and Verapamil Label ), XANAX (Unk, Bid) (View Xanax Review and Xanax Label ), AMBIEN (Unk, Qhs) (View Ambien Review and Ambien Label ), NARCODORM (4 Df, Unk) (View Narcodorm Review and Narcodorm Label ). Patient was hospitalized and became disabled.


6880371-7 | Chromaturia, Decreased Appetite, Faeces Discoloured, Jaundice, Jaundice Cholestatic, Liver Function Test Abnormal, Nausea, Ocular Icterus, Pruritus
on Jul 19, 2010 Female patient from CHINA , 74 years of age, was diagnosed with basedow's disease and was treated with Tapazole (View Usage). Patient had the following side effects: chromaturia, decreased appetite, faeces discoloured, jaundice (What is jaundice?), jaundice cholestatic, liver function test abnormal, nausea (What is nausea?), ocular icterus, pruritus. Tapazole dosage: 10 Mg, Tid. During the same period patient was treated with PROPRANOLOL (10 Mg, Tid) (View Propranolol Review and Propranolol Label ). Patient was hospitalized.

6880368-7 | Abdominal Pain, Hepatic Necrosis, Hepatitis Cholestatic, Jaundice, Liver Function Test Abnormal
Patient was taking Tapazole (View Usage). After Tapazole was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), hepatic necrosis, hepatitis cholestatic, jaundice (What is jaundice?), liver function test abnormal on Jul 19, 2010 from BRAZIL Additional patient health information: Female patient , 47 years of age, was diagnosed with basedow's disease, obesity (What is obesity?) and. Tapazole dosage: 40 Mg, Qd. During the same period patient was treated with SIBUTRAMINE (10 Mg, Qd) (View Sibutramine Review and Sibutramine Label ), DIET FORMULATIONS FOR TREATMENT OF OBESITY (Unk) (View Diet Formulations For Treatment Of Obesity Review and Diet Formulations For Treatment Of Obesity Label ). Patient was hospitalized.

6822037-5 | Agranulocytosis, Pharyngeal Abscess, Respiratory Failure, Serratia Test Positive, Streptococcus Test Positive
Adverse event was reported on Jun 28, 2010 by a Female patient taking Tapazole (View Usage) (Dosage: Unk) was diagnosed with basedow's disease and. Location: UNITED STATES , 47 years of age, Patient experienced the following unwanted or unexpected effects: agranulocytosis, pharyngeal abscess, respiratory failure, serratia test positive, streptococcus test positive. Patient was hospitalized.

6755740-6 | Asthenia, Jaundice, Oral Herpes, Thrombocytopenia
on May 25, 2010 Female patient from UNITED KINGDOM , 71 years of age, was treated with Tapazole (View Usage). Patient had the following side effects: asthenia, jaundice (What is jaundice?), oral herpes, thrombocytopenia. Tapazole dosage: Unk. Patient was hospitalized.

6745723-4 | Heart Rate Increased, Hypersensitivity, Oedema Peripheral, Skin Discolouration
on May 19, 2010 Female patient from UNITED STATES , weighting 168.0 lb, was diagnosed with basedow's disease and was treated with Tapazole (View Usage). After Tapazole was administered, patient had the following side effects: heart rate increased, hypersensitivity, oedema peripheral, skin discolouration. Tapazole dosage: Unk. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6743082-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Cholecystitis Acute, Cholestasis, Escherichia Bacteraemia, Fatigue, Leukocytosis, Ocular Icterus
Patient was taking Tapazole (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, cholecystitis acute, cholestasis, escherichia bacteraemia, fatigue, leukocytosis, ocular icterus on May 17, 2010 from TAIWAN, PROVINCE OF CHINA Additional patient health information: Male patient , 69 years of age, weighting 85.98 lb, was diagnosed with basedow's disease, hyperthyroidism and. Tapazole dosage: 30 Mg, Qd. During the same period patient was treated with PROPRANOLOL (10 Mg, Tid) (View Propranolol Review and Propranolol Label ). Patient was hospitalized.

6701532-3 | Dysgeusia, Increased Upper Airway Secretion
Adverse event was reported on Apr 27, 2009 by a Male patient taking Tapazole (View Usage) (Dosage: 25 Mg, Qd) was diagnosed with thyroid disorder, pruritus, glaucoma (What is glaucoma?) and. Location: UNITED STATES , weighting 190.0 lb, Patient had the following side effects: dysgeusia, increased upper airway secretion. During the same period patient was treated with VISTARIL (Unk, Prn) (View Vistaril Review and Vistaril Label ), ALPHAGAN /01341101/ (Unk, Qd) (View Alphagan /01341101/ Review and Alphagan /01341101/ Label ), XALATAN (Unk, Bid) (View Xalatan Review and Xalatan Label ), ALCON AXOPT (Unk, Qd) (View Alcon Axopt Review and Alcon Axopt Label ).

6701531-1 | Hypoaesthesia Oral
on Jul 15, 2009 Female patient from UNITED STATES , 18 years of age, was diagnosed with hyperthyroidism and was treated with Tapazole (View Usage). After Tapazole was administered, patient had the following side effects: hypoaesthesia oral. Tapazole dosage: Unk, Qd.

6582315-4 | Abdominal Pain Upper, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Faeces Pale, Gamma-glutamyltransferase Increased, Hepatic Steatosis, Hepatitis Cholestatic
on Feb 02, 2010 Male patient from ITALY , 54 years of age, weighting 158.7 lb, was diagnosed with basedow's disease and was treated with Tapazole (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, faeces pale, gamma-glutamyltransferase increased, hepatic steatosis, hepatitis cholestatic. Tapazole dosage: 30 Mg, Qd. Patient was hospitalized.

6476559-X | Agranulocytosis, Dysphagia, Dyspnoea, Hypotension, Microcytic Anaemia, Mucormycosis, Nasal Mucosal Disorder, Nasal Necrosis, Neutropenia
Patient was taking Tapazole (View Usage). Patient had the following side effects: agranulocytosis, dysphagia, dyspnoea, hypotension, microcytic anaemia, mucormycosis, nasal mucosal disorder, nasal necrosis, neutropenia on Nov 25, 2009 from MEXICO Additional patient health information: Female patient , 34 years of age, was diagnosed with goitre and. Tapazole dosage: 15 Mg, Qd. During the same period patient was treated with PROPRANOLOL HYDROCHLORIDE (20 Mg, Qd) (View Propranolol Hydrochloride Review and Propranolol Hydrochloride Label ), PREDNISONE (50 Mg, Qd) (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6453203-9 | Agranulocytosis, Dysphagia, Dyspnoea, Hypotension, Microcytic Anaemia, Nasal Mucosal Disorder, Nasal Necrosis, Neutropenia, Odynophagia
Adverse event was reported on Nov 16, 2009 by a Female patient taking Tapazole (View Usage) (Dosage: 15 Mg, Qd) was diagnosed with goitre and. Location: MEXICO , 34 years of age, After Tapazole was administered, patient had the following side effects: agranulocytosis, dysphagia, dyspnoea, hypotension, microcytic anaemia, nasal mucosal disorder, nasal necrosis, neutropenia, odynophagia. During the same period patient was treated with PROPRANOLOL HYDROCHLORIDE (20 Mg, Qd) (View Propranolol Hydrochloride Review and Propranolol Hydrochloride Label ), PREDNISONE (50 Mg, Qd) (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6437436-3 | Anti-neutrophil Cytoplasmic Antibody Positive Vasculitis, Arthralgia, Dyspnoea, Glomerulonephritis, Haematuria, Haemoptysis, Lung Infiltration, Pulmonary Haemorrhage
on Nov 02, 2009 Female patient from HONG KONG , 44 years of age, was treated with Tapazole (View Usage). Patient experienced the following unwanted or unexpected effects: anti-neutrophil cytoplasmic antibody positive vasculitis, arthralgia, dyspnoea, glomerulonephritis, haematuria, haemoptysis, lung infiltration, pulmonary haemorrhage. Tapazole dosage: 15 Mg, Qd. Patient was hospitalized.

6391680-2 | Cholestatic Liver Injury
on Sep 28, 2009 Female patient from CHINA , 54 years of age, was treated with Tapazole (View Usage). Patient had the following side effects: cholestatic liver injury. Tapazole dosage: Unk. Patient was hospitalized.

6356287-1 | Benign Intracranial Hypertension, Eye Irritation, Ocular Hyperaemia, Pupils Unequal
Patient was taking Tapazole (View Usage). After Tapazole was administered, patient had the following side effects: benign intracranial hypertension, eye irritation, ocular hyperaemia, pupils unequal on Sep 10, 2009 from UNITED STATES Additional patient health information: Female patient , 15 years of age, weighting 117.5 lb, was diagnosed with hyperthyroidism and. Tapazole dosage: 10 Mg, Bid.

6313820-3 | Bilirubin Conjugated Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Hepatic Enzyme Increased, Jaundice, Serum Ferritin Increased
Adverse event was reported on Aug 17, 2009 by a Male patient taking Tapazole (View Usage) (Dosage: ) was diagnosed with hyperthyroidism and. Location: UNITED STATES , 79 years of age, weighting 146.0 lb, Patient experienced the following unwanted or unexpected effects: bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, hepatic enzyme increased, jaundice (What is jaundice?), serum ferritin increased. Patient was hospitalized and became disabled.

6302896-5 | Akathisia, Dyskinesia, Psychomotor Hyperactivity, Restlessness
on Aug 04, 2009 Female patient from UNITED STATES , 53 years of age, was diagnosed with hyperthyroidism, basedow's disease, major depression and was treated with Tapazole (View Usage). Patient had the following side effects: akathisia, dyskinesia, psychomotor hyperactivity, restlessness. Tapazole dosage: 30 Mg, Qd. During the same period patient was treated with VENLAFAXINE HYDROCHLORIDE (150 Mg, Qd) (View Venlafaxine Hydrochloride Review and Venlafaxine Hydrochloride Label ), AMLODIPINE (5 Mg, Qd) (View Amlodipine Review and Amlodipine Label ), BISOPROLOL (5 Mg, Qd) (View Bisoprolol Review and Bisoprolol Label ), CLOPIDOGREL (75 Mg, Qd) (View Clopidogrel Review and Clopidogrel Label ), GLIPIZIDE (10 Mg, Qd) (View Glipizide Review and Glipizide Label ).

6299555-4 | Product Substitution Issue
on Aug 05, 2009 Male patient from UNITED STATES , 14 years of age, weighting 13.00 lb, was diagnosed with hyperthyroidism and was treated with Tapazole (View Usage). After Tapazole was administered, patient had the following side effects: product substitution issue. Tapazole dosage: 30mg Daily Po.

6164694-5 | Blood Glucose Increased, Dental Caries, Diabetes Mellitus, Dry Eye, Hunger, Polyuria, Rash Pruritic, Thirst, Tooth Disorder
Patient was taking Tapazole (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, dental caries, diabetes mellitus, dry eye, hunger, polyuria, rash pruritic, thirst, tooth disorder (What is tooth disorder?) on Jul 24, 2008 from UNITED STATES Additional patient health information: Female patient , 60 years of age, weighting 127.0 lb, was diagnosed with hyperthyroidism and. Tapazole dosage: 10 Mg, Bid.

6164691-X | Sensation Of Foreign Body, Swelling Face, Weight Increased
Adverse event was reported on Apr 23, 2008 by a Female patient taking Tapazole (View Usage) (Dosage: 5 Mg, Qd) was diagnosed with thyroid disorder, fibromyalgia, asthma (What is asthma?) and. Location: UNITED STATES , weighting 208.0 lb, Patient had the following side effects: sensation of foreign body, swelling face, weight increased. During the same period patient was treated with LYRICA (100 Mg, Tid) (View Lyrica Review and Lyrica Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ).

6164672-6 | Activities Of Daily Living Impaired, Arthralgia, Gait Disturbance, Myalgia, Vomiting, Weight Decreased
on Aug 04, 2008 Female patient from UNITED STATES , 54 years of age, weighting 135.0 lb, was diagnosed with hyperthyroidism and was treated with Tapazole (View Usage). After Tapazole was administered, patient had the following side effects: activities of daily living impaired, arthralgia, gait disturbance, myalgia, vomiting, weight decreased. Tapazole dosage: 40 Mg, Qd.

6164671-4 | Hypothyroidism, Paraesthesia
on Mar 11, 2009 Female patient from UNITED STATES , weighting 170.0 lb, was diagnosed with basedow's disease, migraine (What is migraine?), palpitations and was treated with Tapazole (View Usage). Patient experienced the following unwanted or unexpected effects: hypothyroidism, paraesthesia. Tapazole dosage: 30 Mg, Qd. During the same period patient was treated with ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), MAXALT /01406501/ (Unk) (View Maxalt /01406501/ Review and Maxalt /01406501/ Label ), ATENOLOL (Unk) (View Atenolol Review and Atenolol Label ).

6164670-2 | Rectal Haemorrhage
Patient was taking Tapazole (View Usage). Patient had the following side effects: rectal haemorrhage on Aug 12, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 147.0 lb, was diagnosed with thyroid disorder, constipation (What is constipation?) and. Tapazole dosage: 10 Mg, Unk. During the same period patient was treated with MILK OF MAGNESIA TAB (30 Ml, Qd) (View Milk Of Magnesia Tab Review and Milk Of Magnesia Tab Label ), PROPYL THIOURACIL (View Propyl-thiouracil Review and Propyl-thiouracil Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), OXYBUTIN (View Oxybutin Review and Oxybutin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ).

6164669-6 | Breast Cyst
Adverse event was reported on Jun 13, 2008 by a Female patient taking Tapazole (View Usage) (Dosage: 20 Mg, Qd) was diagnosed with hyperthyroidism and. Location: UNITED STATES , 47 years of age, weighting 120.0 lb, After Tapazole was administered, patient had the following side effects: breast cyst. During the same period patient was treated with ATENOLOL (25 Mg, Qd) (View Atenolol Review and Atenolol Label ).

6112410-5 | Anorexia, Asthenia, Azotaemia, Back Pain, Benign Pancreatic Neoplasm, Cardiac Failure, Dysuria, Fatigue, Glomerulonephritis
on Mar 05, 2009 Female patient from JAPAN , 72 years of age, weighting 83.11 lb, was diagnosed with basedow's disease and was treated with Tapazole (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, asthenia, azotaemia, back pain (What is back pain?), benign pancreatic neoplasm, cardiac failure, dysuria, fatigue, glomerulonephritis. Tapazole dosage: Unk. During the same period patient was treated with METHYLPREDNISOLONE 4MG TAB (0.5 G, Qd) (View Methylprednisolone 4mg Tab Review and Methylprednisolone 4mg Tab Label ). Patient was hospitalized.

6109538-2 | Activities Of Daily Living Impaired, Ligament Rupture, Movement Disorder, Neuropathy Peripheral, Pain, Tendon Rupture
on Mar 06, 2009 Female patient from UNITED STATES , 50 years of age, weighting 160.0 lb, was diagnosed with thyroid disorder and was treated with Tapazole (View Usage). Patient had the following side effects: activities of daily living impaired, ligament rupture, movement disorder (What is movement disorder?), neuropathy peripheral, pain (What is pain?), tendon rupture. Tapazole dosage: 1 Tablets Once Every 12 Hour Continueing.

6088728-1 | Anaemia, Anorexia, Ascites, Azotaemia, Back Pain, Benign Pancreatic Neoplasm, Cardiac Failure, Dysuria, Glomerulonephritis
Patient was taking Tapazole (View Usage). After Tapazole was administered, patient had the following side effects: anaemia, anorexia, ascites, azotaemia, back pain (What is back pain?), benign pancreatic neoplasm, cardiac failure, dysuria, glomerulonephritis on Feb 16, 2009 from JAPAN Additional patient health information: Female patient , 72 years of age, was diagnosed with basedow's disease and. Tapazole dosage: Unk. During the same period patient was treated with METHYLPREDNISOLONE 4MG TAB (0.5 G, Qd) (View Methylprednisolone 4mg Tab Review and Methylprednisolone 4mg Tab Label ). Patient was hospitalized.

6050966-1 | Agranulocytosis, Oropharyngeal Pain, Periorbital Cellulitis, Pyrexia
Adverse event was reported on Jan 22, 2009 by a Female patient taking Tapazole (View Usage) (Dosage: 10 Mg Daily Po) was diagnosed with basedow's disease and. Location: UNITED STATES , 28 years of age, weighting 186.0 lb, Patient experienced the following unwanted or unexpected effects: agranulocytosis, oropharyngeal pain, periorbital cellulitis, pyrexia. During the same period patient was treated with PROPRANOLOL (View Propranolol Review and Propranolol Label ). Patient was hospitalized.

5965161-1 | Arthralgia, Bladder Mass, Breast Cancer Stage Iv, Burning Sensation, Connective Tissue Disorder, Cutaneous Vasculitis, Cystitis, Hepatic Neoplasm, Pain Of Skin
on Nov 11, 2008 Female patient from UNITED STATES , 63 years of age, was diagnosed with toxic nodular goitre, breast cancer (What is breast cancer?) and was treated with Tapazole (View Usage). Patient had the following side effects: arthralgia, bladder mass, breast cancer stage iv, burning sensation, connective tissue disorder (What is connective tissue disorder?), cutaneous vasculitis, cystitis, hepatic neoplasm, pain of skin. Tapazole dosage: Unk. During the same period patient was treated with GABAPENTIN (Unk) (View Gabapentin Review and Gabapentin Label ), ANASTROZOLE (Unk) (View Anastrozole Review and Anastrozole Label ), LETROZOLE (Unk) (View Letrozole Review and Letrozole Label ), TRASTUZUMAB (Unk) (View Trastuzumab Review and Trastuzumab Label ), FULVESTRANT (Unk) (View Fulvestrant Review and Fulvestrant Label ), TAMOXIFEN (Unk) (View Tamoxifen Review and Tamoxifen Label ).

5965160-X | Headache, Paraesthesia, Vasculitis Cerebral
on Nov 11, 2008 Female patient from ITALY , 22 years of age, was diagnosed with basedow's disease and was treated with Tapazole (View Usage). After Tapazole was administered, patient had the following side effects: headache (What is headache?), paraesthesia, vasculitis cerebral. Tapazole dosage: 30 Mg, Qd. Patient was hospitalized.

5903358-7 | Congenital Absence Of Bile Ducts, Jaundice Neonatal
Patient was taking Tapazole (View Usage). Patient experienced the following unwanted or unexpected effects: congenital absence of bile ducts, jaundice neonatal on Sep 18, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 3.09 lb, . Tapazole dosage: Unk, Unk.

5701789-1 | Abasia, Basedow's Disease, Condition Aggravated, Coordination Abnormal, Delusion, Muscular Weakness, White Blood Cell Count Decreased
Adverse event was reported on Apr 10, 2008 by a Female patient taking Tapazole (View Usage) (Dosage: 30 Mg Once Daily Oral) was diagnosed with psychomotor hyperactivity and. Location: UNITED STATES , 72 years of age, weighting 80.00 lb, Patient had the following side effects: abasia, basedow's disease, condition aggravated, coordination abnormal, delusion, muscular weakness, white blood cell count decreased. During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), CALCIUM TAB (View Calcium Tab Review and Calcium Tab Label ). Patient was hospitalized.

5492310-4 | Amnesia, Eating Disorder, Fall, Sexual Dysfunction, Sleep Talking, Somnambulism, Victim Of Sexual Abuse
on Jul 17, 2007 Female patient from UNITED STATES , weighting 119.9 lb, was diagnosed with hyperthyroidism and was treated with Tapazole (View Usage). After Tapazole was administered, patient had the following side effects: amnesia, eating disorder (What is eating disorder?), fall (What is fall?), sexual dysfunction, sleep talking, somnambulism, victim of sexual abuse. Tapazole dosage: Unk. During the same period patient was treated with AMBIEN (Started With 10 Mg + Went Down To 5 Mg Hs) (View Ambien Review and Ambien Label ).

5394406-4 | Amnesia, Eating Disorder, Fall, Sexual Dysfunction, Sleep Talking, Somnambulism, Victim Of Sexual Abuse
on Jul 11, 2007 Female patient from UNITED STATES , weighting 119.9 lb, was treated with Tapazole (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, eating disorder (What is eating disorder?), fall (What is fall?), sexual dysfunction, sleep talking, somnambulism, victim of sexual abuse. Tapazole dosage: Unk. During the same period patient was treated with AMBIEN (Started With 10mg + Went Down To 5 Mg Hs) (View Ambien Review and Ambien Label ).

5347656-7 | Asthenia, Chest Pain, Eye Haemorrhage, Heart Rate Increased, Pharyngolaryngeal Pain
Patient was taking Tapazole (View Usage). Patient had the following side effects: asthenia, chest pain (What is chest pain?), eye haemorrhage, heart rate increased, pharyngolaryngeal pain on Jun 04, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 132.0 lb, was diagnosed with hyperthyroidism and. Tapazole dosage: 10 Mg 5 Pills 3 Time Day.

5344220-0 | Agranulocytosis, Leukopenia
Adverse event was reported on May 31, 2007 by a Female patient taking Tapazole (View Usage) (Dosage: ) was diagnosed with hyperthyroidism and. Location: UNITED STATES , 80 years of age, After Tapazole was administered, patient had the following side effects: agranulocytosis, leukopenia. During the same period patient was treated with AZTREONAM (View Aztreonam Review and Aztreonam Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), HEPARIN (View Heparin Review and Heparin Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ), AVELOX (View Avelox Review and Avelox Label ), ALDACTONE (View Aldactone Review and Aldactone Label ). Patient was hospitalized.

5220700-3 | Alanine Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Neutrophil Count Decreased, White Blood Cell Count Decreased
on Jan 25, 2007 Female patient from UNITED STATES , 46 years of age, weighting 224.0 lb, was diagnosed with basedow's disease and was treated with Tapazole (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, neutrophil count decreased, white blood cell count decreased. Tapazole dosage: 10 Mg Tid. During the same period patient was treated with BONIVA (View Boniva Review and Boniva Label ), RESTORIL (View Restoril Review and Restoril Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), PROZAC (View Prozac Review and Prozac Label ).

5220697-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased
on Jan 25, 2007 Female patient from UNITED STATES , 42 years of age, weighting 144.0 lb, was diagnosed with basedow's disease and was treated with Tapazole (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased. Tapazole dosage: 10 Mg Bid. During the same period patient was treated with PROPRANOLOL (View Propranolol Review and Propranolol Label ).

4740936-5 | C-reactive Protein Increased, Chest Pain, Glomerulonephritis, Haematuria, Haemoglobinuria, Hypertension, Hypothyroidism, Oedema Peripheral, Pleural Effusion
Patient was taking Tapazole (View Usage). After Tapazole was administered, patient had the following side effects: c-reactive protein increased, chest pain (What is chest pain?), glomerulonephritis, haematuria, haemoglobinuria, hypertension, hypothyroidism, oedema peripheral, pleural effusion on Aug 02, 2005 from UNITED STATES Additional patient health information: Female patient , 16 years of age, weighting 154.3 lb, was diagnosed with basedow's disease and. Tapazole dosage: . Patient was hospitalized.

4713424-X | Cellulitis, Immunosuppression, Malaise, Pharyngitis, Pyrexia, Septic Shock, Swelling, White Blood Cell Count Decreased
Adverse event was reported on Jul 06, 2005 by a Female patient taking Tapazole (View Usage) (Dosage: 10 Mg, Qd) was diagnosed with hyperthyroidism, pharyngitis and. Location: BRAZIL , 25 years of age, Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?), immunosuppression, malaise, pharyngitis, pyrexia, septic shock, swelling, white blood cell count decreased. During the same period patient was treated with NIMESULIDE (10 Mg, Unk) (View Nimesulide Review and Nimesulide Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ). Patient was hospitalized.

4598802-4 | Fatigue, Hypoaesthesia, Migraine, Paraesthesia
on Mar 01, 2005 Female patient from , 50 years of age, weighting 115.0 lb, was diagnosed with basedow's disease, hyperthyroidism and was treated with Tapazole (View Usage). Patient had the following side effects: fatigue, hypoaesthesia, migraine (What is migraine?), paraesthesia. Tapazole dosage: 5 Mg X2 Oral.

4582403-8 | Heart Rate Increased, Thyroid Disorder, Weight Decreased
on Feb 11, 2005 Female patient from , 40 years of age, was diagnosed with hyperthyroidism and was treated with Tapazole (View Usage). After Tapazole was administered, patient had the following side effects: heart rate increased, thyroid disorder, weight decreased. Tapazole dosage: 10 Mg 2xs Day. Patient was hospitalized and became disabled.